Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tau as a therapeutic target for Alzheimer's disease.
Boutajangout A, Sigurdsson EM, Krishnamurthy PK. Boutajangout A, et al. Among authors: sigurdsson em. Curr Alzheimer Res. 2011 Sep;8(6):666-77. doi: 10.2174/156720511796717195. Curr Alzheimer Res. 2011. PMID: 21679154 Free PMC article. Review.
Immunotherapy for tauopathies.
Gu J, Sigurdsson EM. Gu J, et al. Among authors: sigurdsson em. J Mol Neurosci. 2011 Nov;45(3):690-5. doi: 10.1007/s12031-011-9576-5. Epub 2011 Jul 8. J Mol Neurosci. 2011. PMID: 21739165 Free PMC article. Review.
Tau immunotherapy for Alzheimer's disease.
Pedersen JT, Sigurdsson EM. Pedersen JT, et al. Among authors: sigurdsson em. Trends Mol Med. 2015 Jun;21(6):394-402. doi: 10.1016/j.molmed.2015.03.003. Epub 2015 Apr 3. Trends Mol Med. 2015. PMID: 25846560 Review.
Tau Immunotherapy.
Sigurdsson EM. Sigurdsson EM. Neurodegener Dis. 2016;16(1-2):34-8. doi: 10.1159/000440842. Epub 2015 Nov 10. Neurodegener Dis. 2016. PMID: 26551002 Free PMC article. Review.
In recent years, tau immunotherapy has advanced from proof-of-concept studies [Sigurdsson EM, NIH R01AG020197, 2001; Asuni AA, et al: J Neurosci 2007;27:9115-9129], which have now been confirmed and extended by us and others. ...
In recent years, tau immunotherapy has advanced from proof-of-concept studies [Sigurdsson EM, NIH R01AG020197, 2001; Asuni AA, …
103 results